Don’t Shortchange COVID-19 Vax Approval Process, House Panel Told

Any vaccine against COVID-19 should undergo a transparent approval process and the FDA should not “cut corners” in order to rush a vaccine to market without being assured of its safety and efficacy, experts told a House subcommittee on Tuesday. To that end, vaccine manufacturers need large-scale clinical trials of at least 30,000 participants, as…Continue Reading